{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:10:22Z","timestamp":1793211022506,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1053\/j.gastro.2017.02.027","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T21:15:18Z","timestamp":1488402918000},"page":"932-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the \u201cReal World\u201d"],"prefix":"10.1053","volume":"152","author":[{"given":"Micha\u0142","family":"Mazurek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2017.02.027_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.02.027_bib2","first-page":"781","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel","volume":"111","author":"Husted","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2017.02.027_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1160\/TH16-03-0203","article-title":"Dabigatran in real-world atrial fibrillation. Meta-analysis of observational comparison studies with vitamin K antagonists","volume":"116","author":"Carmo","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib5","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1160\/TH15-06-0453","article-title":"A\u00a0comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system","volume":"114","author":"Villines","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1160\/TH15-03-0247","article-title":"Dabigatran use in elderly patients with atrial fibrillation","volume":"115","author":"Avgil-Tsadok","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib7","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/jamainternmed.2016.5954","article-title":"Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation","volume":"176","author":"Graham","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.gastro.2017.02.027_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1160\/TH16-05-0403","article-title":"Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis","volume":"116","author":"Lip","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1160\/TH16-06-0485","article-title":"Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice","volume":"116","author":"Beyer-Westendorf","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/j.gastro.2016.12.018","article-title":"Gastrointestinal safety of direct oral anticoagulants: a large population-based study","volume":"152","author":"Abraham","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.02.027_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.chest.2016.07.013","article-title":"Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation","volume":"150","author":"Noseworthy","year":"2016","journal-title":"Chest"},{"key":"10.1053\/j.gastro.2017.02.027_bib12","first-page":"5","article-title":"Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation","author":"Yao","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1053\/j.gastro.2017.02.027_bib13","first-page":"465","article-title":"Evaluation of patients\u2019 attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"LaHaye","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1053\/j.gastro.2017.02.027_bib15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.amjmed.2016.03.024","article-title":"Major outcomes in atrial fibrillation patients with one risk factor: impact of time in therapeutic range observations from the SPORTIF trials","volume":"129","author":"Proietti","year":"2016","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2017.02.027_bib16","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.jacc.2015.07.086","article-title":"Matching the NOAC to the patient","volume":"66","author":"Lip","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.gastro.2017.02.027_bib17","first-page":"381","article-title":"Patient\u2019s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation","volume":"111","author":"Lane","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib18","first-page":"209","article-title":"Adherence to oral anticoagulant therapy in patients with atrial fibrillation","volume":"117","author":"Raparelli","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.gastro.2017.02.027_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","article-title":"Stroke prevention in atrial fibrillation","volume":"388","author":"Freedman","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2017.02.027_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2013.12.006","article-title":"Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation","volume":"167","author":"Huisman","year":"2014","journal-title":"Am Heart J"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517302147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517302147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:16:11Z","timestamp":1758035771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508517302147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0016508517302147"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2017.02.027","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the \u201cReal World\u201d","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2017.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2016.12.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}